drugset / Trial / NCT03103295
3D Tissue Engineered Bone Equivalent for Treatment of Traumatic Bone Defects
NaSingle-groupOpen-labelTreatment
Summary
This study investigates safety and efficacy of traumatic bone defects treatment with use of 3D tissue engineered bone equivalent (3D-TEBE). The aim of this study is to evaluate 3D-TEBE transplantation as a safe and efficient treatment for patients with traumatic long bone defects of critical size.
Timeline
- Start
- 2015-11-20
- Primary completion
- 2018-12-20
- Completion
- 2018-12-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 3D-Tissue Engineered Bone Equivalent | Cell therapy | — | — |